NO176761C - Analogifremgangsmåte for fremstilling av terapeutisk aktive P-substituerte aminoalkylfosfinsyrer - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive P-substituerte aminoalkylfosfinsyrer

Info

Publication number
NO176761C
NO176761C NO902109A NO902109A NO176761C NO 176761 C NO176761 C NO 176761C NO 902109 A NO902109 A NO 902109A NO 902109 A NO902109 A NO 902109A NO 176761 C NO176761 C NO 176761C
Authority
NO
Norway
Prior art keywords
denotes
preparation
hydrogen
therapeutically active
phosphinic acids
Prior art date
Application number
NO902109A
Other languages
English (en)
Norwegian (no)
Other versions
NO902109D0 (no
NO902109L (no
NO176761B (no
Inventor
Roger Graham Hall
Ludwig Maier
Wolfgang Frostl
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO902109D0 publication Critical patent/NO902109D0/no
Publication of NO902109L publication Critical patent/NO902109L/no
Publication of NO176761B publication Critical patent/NO176761B/no
Publication of NO176761C publication Critical patent/NO176761C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/36—Amides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Luminescent Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
NO902109A 1989-05-13 1990-05-11 Analogifremgangsmåte for fremstilling av terapeutisk aktive P-substituerte aminoalkylfosfinsyrer NO176761C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898911017A GB8911017D0 (en) 1989-05-13 1989-05-13 Substituted aminoalkylphosphinic acids

Publications (4)

Publication Number Publication Date
NO902109D0 NO902109D0 (no) 1990-05-11
NO902109L NO902109L (no) 1990-11-14
NO176761B NO176761B (no) 1995-02-13
NO176761C true NO176761C (no) 1995-05-24

Family

ID=10656689

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902109A NO176761C (no) 1989-05-13 1990-05-11 Analogifremgangsmåte for fremstilling av terapeutisk aktive P-substituerte aminoalkylfosfinsyrer

Country Status (24)

Country Link
EP (1) EP0399949B1 (de)
JP (1) JP2930366B2 (de)
KR (1) KR0159501B1 (de)
AT (1) ATE121095T1 (de)
AU (1) AU629335B2 (de)
CA (1) CA2016631C (de)
DD (1) DD294265A5 (de)
DE (1) DE69018514T2 (de)
DK (1) DK0399949T3 (de)
ES (1) ES2070303T3 (de)
FI (1) FI94416C (de)
GB (1) GB8911017D0 (de)
GR (1) GR3015770T3 (de)
HR (1) HRP940178A2 (de)
HU (1) HU206885B (de)
IE (1) IE66165B1 (de)
IL (1) IL94317A (de)
MX (1) MX20639A (de)
NO (1) NO176761C (de)
NZ (1) NZ233647A (de)
PT (1) PT94014B (de)
SI (1) SI9010917B (de)
YU (1) YU91790A (de)
ZA (1) ZA903611B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
US6001876A (en) 1996-07-24 1999-12-14 Warner-Lambert Company Isobutylgaba and its derivatives for the treatment of pain
CN1309659A (zh) 1998-07-15 2001-08-22 哈桑·朱马 有机磷化合物及其用途
GB9906882D0 (en) * 1999-03-25 1999-05-19 Novartis Ag Organic compounds
SE9904508D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
SE9904507D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
AR033779A1 (es) 2001-06-08 2004-01-07 Astrazeneca Ab Compuestos utiles en la enfermedad de reflujo
SE0102055D0 (sv) * 2001-06-08 2001-06-08 Astrazeneca Ab New Compounds
WO2005060968A1 (en) 2003-12-11 2005-07-07 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
BRPI0620372A2 (pt) 2005-12-23 2011-11-08 Astrazeneca Ab composto, composição farmaceutica, e, uso de um composto
BRPI0620464A2 (pt) 2005-12-23 2011-11-16 Astrazeneca Ab composto, composição farmacêutica, uso de um composto, e, método para o tratamento de uma doença
DE102008056228A1 (de) * 2008-11-06 2010-05-12 Clariant International Limited Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, deren Salze und Ester und ihre Verwendung
DE102008056339A1 (de) * 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von mono-aminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
EP3753410A3 (de) 2010-09-28 2021-04-28 The Regents Of The University Of California Kombinationen enthaltend gaba agonisten zur behandlung von hyperglyzemie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3311475C1 (de) * 1983-03-29 1984-08-16 Siemens AG, 1000 Berlin und 8000 München Mikroprogramm-Steuereinrichtung
DE3312165A1 (de) * 1983-04-02 1984-10-04 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von phosphinothricin
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds

Also Published As

Publication number Publication date
FI94416B (fi) 1995-05-31
GB8911017D0 (en) 1989-06-28
KR900018124A (ko) 1990-12-20
HU206885B (en) 1993-01-28
NO902109D0 (no) 1990-05-11
NO902109L (no) 1990-11-14
FI94416C (fi) 1995-09-11
DK0399949T3 (da) 1995-07-03
KR0159501B1 (ko) 1999-01-15
PT94014B (pt) 1996-12-31
NZ233647A (en) 1992-08-26
IE901716L (en) 1990-11-13
EP0399949A1 (de) 1990-11-28
DE69018514T2 (de) 1995-09-21
HRP940178A2 (en) 1996-08-31
ES2070303T3 (es) 1995-06-01
ZA903611B (en) 1991-02-27
HUT53656A (en) 1990-11-28
JP2930366B2 (ja) 1999-08-03
IL94317A0 (en) 1991-03-10
IE66165B1 (en) 1995-12-13
SI9010917A (en) 1997-06-30
FI902368A0 (fi) 1990-05-11
CA2016631C (en) 2000-08-29
ATE121095T1 (de) 1995-04-15
NO176761B (no) 1995-02-13
DD294265A5 (de) 1991-09-26
DE69018514D1 (de) 1995-05-18
IL94317A (en) 1997-07-13
HU903012D0 (en) 1990-09-28
AU629335B2 (en) 1992-10-01
EP0399949B1 (de) 1995-04-12
GR3015770T3 (en) 1995-07-31
PT94014A (pt) 1991-01-08
SI9010917B (sl) 1999-10-31
YU91790A (sh) 1992-07-20
AU5480990A (en) 1990-11-15
MX20639A (es) 1993-12-01
CA2016631A1 (en) 1990-11-13
JPH0395195A (ja) 1991-04-19

Similar Documents

Publication Publication Date Title
FI902368A0 (fi) Menetelmä substituoitujen aminoalkyylifosfiinihappojen valmistamiseksi
EP0747383A3 (de) Clavulansäure Polyaminsalze
NZ303251A (en) Use of esters of 5-aminolevulinic acid as photosensitising agents in photochemotherapy
IT1256345B (it) Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
HUT44001A (en) Process for producing new phenoxy-acetamide derivatives and pharmaceutical compositions containing them as active components
MA26457A1 (fr) Vinylpyrrolidone-cephalosporines a substituants basiques, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
AU636351B2 (en) N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
ES8100300A1 (es) Un procedimiento para preparar compuestos de cefem
KR960017669A (ko) 양쪽성 3환식 화합물
DE3782548D1 (de) Ergolin-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammenstellungen.
NZ308024A (en) The reaction product of alkaloids of Chelidonium maius L. with thiophosphoric acid triaziridide is used as radiation treatment medicine
DK634686D0 (da) Dioxahexensyrer, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse
DE3381885D1 (de) Piperidinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate.
FI901994A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminosubstituoitujen silta-atsabisyklisten kinolonikarboksyylihappojen ja -estereiden valmistamiseksi
JO1870B1 (en) CO2 derivatives - pyridinyl benzimidazole innovative
TW263509B (de)
FR2711651B1 (fr) Nouveaux analogues cyclisés de métabolites d'acides gras, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
JO1871B1 (en) Innovative substituted benzimidazole compounds

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2001